{"id":"misotac-sigma-pharmaceutical-industries","safety":{"commonSideEffects":[{"rate":"13–40","effect":"Diarrhea"},{"rate":"7–20","effect":"Abdominal pain"},{"rate":"3–7","effect":"Nausea"},{"rate":"2–5","effect":"Flatulence"}]},"_chembl":{"chemblId":"CHEMBL2109197","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Misoprostol binds to prostaglandin receptors on gastric mucosa cells, enhancing mucus and bicarbonate secretion while simultaneously reducing gastric acid production. It is commonly used to prevent nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers and to promote gastric healing in existing ulcer disease.","oneSentence":"Misoprostol is a prostaglandin E1 analogue that protects the gastric mucosa and reduces acid secretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:21:36.445Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of NSAID-induced gastric ulcers"},{"name":"Treatment of gastric and duodenal ulcers"}]},"trialDetails":[{"nctId":"NCT07271056","phase":"NA","title":"Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-11","conditions":"Scar Niche, Abnormal Uterine Bleeding, Cesarean Section Complications","enrollment":56},{"nctId":"NCT05806307","phase":"PHASE4","title":"Methods Decreasing Bleeding in Open Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03-15","conditions":"Misoprostol Allergy, Oxytocin Allergy, Tranexamic Acid Allergy","enrollment":105},{"nctId":"NCT03930069","phase":"PHASE2, PHASE3","title":"Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2016-05-02","conditions":"Submucous Leiomyoma of Uterus","enrollment":40},{"nctId":"NCT03790371","phase":"PHASE3","title":"Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-10-01","conditions":"Contraception","enrollment":90},{"nctId":"NCT02036437","phase":"PHASE3","title":"Titrated Oral Misoprostol Compared to Vaginal Dinoprostone for Induction of Labor","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2013-09","conditions":"Medical Induction of Labor Affecting Fetus","enrollment":200},{"nctId":"NCT01466530","phase":"PHASE2","title":"Sublingual Misoprostol & Isoflurane During Caesarean Section","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2006-01","conditions":"Pregnancy, Cesarean Delivery","enrollment":366}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Misotac (Misoprostol)"],"phase":"phase_3","status":"active","brandName":"Misotac® Sigma Pharmaceutical Industries","genericName":"Misotac® Sigma Pharmaceutical Industries","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Misoprostol is a prostaglandin E1 analogue that protects the gastric mucosa and reduces acid secretion. Used for Prevention of NSAID-induced gastric ulcers, Treatment of gastric and duodenal ulcers.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}